产品名称 | NebuSelect™ Recombinant Human DLL1/Delta1, His-tag |
---|---|
目录号 | NBL-242743 |
别名 | DLL1/Delta1; H-Delta-1; DLL1; DELTA1; DL1 |
外观 | see COA |
分子量 | Gln18-Gly540 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | NP_005609 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242743-100ug | 100ug | Inquire | Inquire | |
NBL-242743-1mg | 1mg | Inquire | Inquire | |
NBL-242743-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human DLL1/Delta1, His-tag
Catalog#:
NBL-242743
Description:
NebuSelect™ Recombinant Human DLL1/Delta1, His-tag(Cat#NBL-242743) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln18-Gly540.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 57.6 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
DLL1/Delta1; H-Delta-1; DLL1; DELTA1; DL1
Target Information:
DLL1, a Notch signaling ligand, is significantly overexpressed in ERα luminal breast cancer. Intriguingly, DLL1 overexpression correlates with poor prognosis in ERα luminal breast cancer, but not in other subtypes of breast cancer. In addition, this effect is specific to DLL1, as other Notch ligands (DLL3, JAGGED1, and JAGGED2) do not influence the clinical outcome of ERα patients. DLL1-mediated Notch signaling in breast cancer is important for tumor cell proliferation, angiogenesis, and cancer stem cell function.
Amino Acid Sequence:
Gln18-Gly540
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.